scanX
Home
Everest Organics

Everest Organics

135.80
-3.95
(-2.83%)
Market Cap (₹ Cr.)
₹112
52 Week High
184.00
Book Value
₹
52 Week Low
110.00
PE Ratio
PB Ratio
2.81
PE for Sector
42.59
PB for Sector
23.30
ROE
-0.39 %
ROCE
7.92 %
Dividend Yield
2.15 %
EPS
₹0.17
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
4.28 %
Net Income Growth
176.40 %
Cash Flow Change
-10.86 %
ROE
177.02 %
ROCE
61.59 %
EBITDA Margin (Avg.)
44.60 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
31
26
23
23
29
25
30
28
26
24
29
28
33
27
37
40
52
41
40
40
47
43
45
49
45
51
48
47
56
43
46
49
51
43
50
53
53
33
Expenses
28
24
24
22
25
23
28
26
25
23
27
25
31
25
32
34
47
35
36
36
42
37
39
42
41
47
48
45
53
45
43
46
48
40
47
50
50
36
EBITDA
2
2
-1
1
3
2
2
3
1
2
2
3
2
2
4
6
6
6
5
4
5
6
7
7
5
4
0
2
2
-1
3
3
3
3
3
3
3
-3
Operating Profit %
7 %
6 %
-4 %
6 %
11 %
6 %
6 %
7 %
3 %
7 %
7 %
7 %
4 %
8 %
12 %
15 %
10 %
15 %
11 %
10 %
10 %
14 %
14 %
13 %
10 %
8 %
-3 %
4 %
3 %
-4 %
6 %
-6 %
4 %
6 %
5 %
5 %
6 %
-11 %
Depreciation
1
1
1
1
1
1
1
1
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
Interest
1
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Profit Before Tax
1
1
-2
-0
2
0
1
1
0
1
1
1
0
1
3
4
4
5
3
3
4
5
5
5
3
3
-2
0
0
-3
1
1
1
0
0
0
0
-6
Tax
0
0
0
0
-0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
-1
1
1
1
0
0
-0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
1
0
-2
-0
2
0
0
1
0
0
1
1
0
1
2
3
1
3
2
2
4
4
4
4
2
2
-1
0
0
-3
1
2
0
0
0
0
0
-6
EPS in ₹
0.65
0.45
-2.34
-0.38
6.19
0.55
0.60
1.40
0.14
0.61
0.90
1.24
0.48
1.02
2.83
4.35
1.18
4.05
2.36
2.26
4.95
4.47
4.85
5.07
2.75
2.67
-1.68
0.08
0.36
-3.44
1.17
1.90
0.14
0.04
0.04
0.02
0.07
-7.61
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
67
76
86
94
107
120
135
178
202
227
Fixed Assets
24
27
33
34
38
39
44
49
54
52
Current Assets
42
47
49
58
67
79
89
118
132
150
Capital Work in Progress
0
1
1
1
0
1
0
8
12
21
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
42
47
52
60
68
80
92
121
136
153
Total Liabilities
61
70
70
76
81
86
89
131
156
181
Current Liabilities
50
56
63
67
71
74
77
113
138
160
Non Current Liabilities
11
14
7
8
10
12
11
19
18
21
Total Equity
6
6
16
19
26
34
47
47
46
46
Reserve & Surplus
-3
3
8
11
18
26
39
39
38
38
Share Capital
9
3
8
8
8
8
8
8
8
8
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
0
0
-0
1
0
-0
-1
-0
0
Investing Activities
-3
-7
-8
-4
-5
-6
-12
-17
-16
-13
Operating Activities
4
7
10
5
9
10
14
14
18
16
Financing Activities
-2
-0
-2
-1
-3
-3
-2
2
-3
-3
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.06 %
0.06 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
25.82 %
25.82 %
25.82 %
25.82 %
25.82 %
25.82 %
25.82 %
25.82 %
25.82 %
25.82 %
25.82 %
25.82 %
25.79 %
25.79 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,844.75 4,47,691.91 42.46 49,887.17 12.06 9,648 42.62 62.67
Divis Laboratories
5,469.15 1,44,798.52 86.50 8,184.00 0.89 1,600 20.79 74.15
Cipla
1,638.45 1,34,956.56 30.36 26,520.66 14.17 4,155 17.77 55.12
Zydus Life Science
1,058.10 1,11,727.19 26.80 19,831.50 13.82 3,831 30.78 30.15
Dr Reddys Laboratories
6,517.70 1,10,648.92 19.88 28,905.40 12.36 5,578 -0.90 33.67
Lupin
2,168.85 1,03,570.56 45.76 20,141.50 19.94 1,936 77.69 50.23
Mankind Pharma
2,434.70 98,296.04 50.09 10,615.63 19.57 1,942 9.89 56.96
Aurobindo Pharma
1,533.30 90,940.60 25.35 29,559.25 17.55 3,169 61.17 53.71
Alkem Laboratories
6,158.70 74,370.03 34.59 12,978.42 9.84 1,811 91.18 57.26
Glenmark Pharmaceuticals
1,663.05 48,348.71 24.27 12,653.09 6.58 -1,831 96.52 51.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
43.98
ATR(14)
Less Volatile
8.25
STOCH(9,6)
Oversold
15.70
STOCH RSI(14)
Neutral
39.44
MACD(12,26)
Bullish
0.27
ADX(14)
Weak Trend
12.08
UO(9)
Bearish
30.14
ROC(12)
Uptrend But Slowing Down
0.15
WillR(14)
Oversold
-88.92
Bearish
3
Neutral
4
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore
Technical Screeners
Price & Volume Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.